Patents Assigned to Jiangsu Puxin Pharmaceutical Co., Ltd.
  • Patent number: 10214480
    Abstract: Provided is a synthesis process for a chiral cyclopropyl ethynyl tertiary alcohol compound, where a chiral amino alcohol or a chiral amino diol is reacted in the presence of an alkaline reagent and a salt to obtain an optically active propynyl alcohol compound. In particular, the process includes (1) reacting cyclopropyl acetylene with a chiral inducing agent, a chiral auxiliary reagent and zinc halide in an organic solvent in the presence of an alkaline reagent and a sulfonate or a sulphinate to obtain a first reaction mixture; (2) reacting the resultant first reaction mixture with 5-chloro-2-aminotrifluorobenzophenone to form (S)-2-amino-5-chloro-?-cyclopropyl acetylene-?-trifluoromethylbenzyl alcohol. The process avoids an organic zinc reagent and a Grignard reagent, and has the advantages of safe production, an environmentally friendly route, low production costs, a high resultant product yield, a high chiral ee value and is suitable for industrial production.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: February 26, 2019
    Assignees: Shanghai Desano Pharmaceutical Co., Ltd., Yancheng Desano Pharmaceutical Co., Ltd., Jiangsu Puxin Pharmaceutical Co., Ltd.
    Inventors: Nan Zhao, Fei Jiang
  • Publication number: 20180029975
    Abstract: Provided is a synthesis process for a chiral cyclopropyl ethynyl tertiary alcohol compound, where a chiral amino alcohol or a chiral amino diol is reacted in the presence of an alkaline reagent and a salt to obtain an optically active propynyl alcohol compound. In particular, the process includes (1) reacting cyclopropyl acetylene with a chiral inducing agent, a chiral auxiliary reagent and zinc halide in an organic solvent in the presence of an alkaline reagent and a sulfonate or a sulphinate to obtain a first reaction mixture; (2) reacting the resultant first reaction mixture with 5-chloro-2-aminotrifluorobenzophenone to form (S)-2-amino-5-chloro-?-cyclopropyl acetylene-?-trifluoromethylbenzyl alcohol. The process avoids an organic zinc reagent and a Grignard reagent, and has the advantages of safe production, an environmentally friendly route, low production costs, a high resultant product yield, a high chiral ee value and is suitable for industrial production.
    Type: Application
    Filed: October 23, 2015
    Publication date: February 1, 2018
    Applicants: Shanghai Desano Pharmaceutical Co., Ltd., Yancheng Desano Pharmaceutical Co., Ltd., Jiangsu Puxin Pharmaceutical Co., Ltd.
    Inventors: Nan ZHAO, Fei JIANG